Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States | 34 | 18 |
|
OnkoRisk Hereditary Urology Panel BioReference Health United States | 27 | 19 |
|
BioReference Health United States | 4 | 2 |
|
PathGroup United States | 13 | 1 |
|
24 Genetics 24Genetics SL Spain | 7 | 1 |
|
Breast & Ovarian Cancer, Familial (BRCA1 & BRCA2) Center for Human Genetics, Inc United States | 2 | 2 |
|
Tier 1 Hereditary Conditions Test Color Diagnostics, LLC DBA Color Health United States | 14 | 10 |
|
Genetics Center United States | 1 | 13 |
|
BRCA 1/2 Sequencing & Deletion/Duplication Genetics Center United States | 1 | 2 |
|
PathGroup United States | 73 | 505 |
|
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States | 23 | 3 |
|
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States | 25 | 3 |
|
Color Diagnostics, LLC DBA Color Health United States | 24 | 29 |
|
Color Diagnostics, LLC DBA Color Health United States | 51 | 59 |
|
OnkoSight Advanced GYN Tumor NGS BioReference Health United States | 1 | 50 |
|
Diagnostic Medical Genetics Mount Sinai Hospital, Sinai Health System Canada | 1 | 2 |
|
GENOTYPOS MSA Greece | 3 | 80 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.